Definition and management of invasive fungal rhinosinusitis: a single-centre retrospective study

Gian Luca Fadda1, Federica Martino1,2, Giacomo Andreani3

  • 1Department of Otolaryngology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.

Abstract

Insights

This study analyzed invasive fungal rhinosinusitis, finding diabetes and hematological diseases common in patients. Prompt diagnosis and treatment are crucial for better outcomes in acute invasive fungal rhinosinusitis (AIFRS) and chronic forms.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Radiology

Background:

  • Invasive fungal rhinosinusitis (IFRS) encompasses acute (AIFRS) and chronic forms.
  • Accurate diagnosis and timely treatment are vital to prevent severe complications and mortality.

Purpose of the Study:

  • To correlate AIFRS and chronic invasive fungal rhinosinusitis with patient comorbidities, causative fungi, clinical presentation, and imaging findings.
  • To identify patient subsets requiring enhanced diagnostic evaluation.
  • To guide appropriate surgical and medical management strategies.

Main Methods:

  • Retrospective monocentric study of 17 patients undergoing endoscopic sinus surgery.
  • Evaluation using paranasal computed tomography and magnetic resonance imaging.
  • Analysis of patient demographics, symptoms, fungal etiology, and infection site.

Main Results:

  • 4 patients had AIFRS, 13 had chronic IFRS.
  • Diabetes mellitus (41.17%) and hematological diseases (23.52%) were prevalent comorbidities.
  • Maxillary (47.05%) and sphenoidal (52.94%) sinuses were most frequently involved. Aspergillus fumigatus (76.47%) was the predominant pathogen.

Conclusions:

  • Understanding the distinct features of AIFRS and chronic IFRS is essential for prompt diagnosis.
  • Early initiation of appropriate therapy is critical to avoid prolonged illness or fatal outcomes.
  • Radiological findings and etiological identification aid in targeted treatment.

Related Concept Videos

Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
347
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
305
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
458